Billings Clinic
Especially For:

Clinical Trials

Title   CTSU SCISF0806
Description   A Phase II Placebo-Controled Trial of Lisinopril and Coreg CR to Reduce Cardiotoxicity in Patients with Breast Cancer Receiving (Neo)adjuvant Chemotherapy with Trastuzumab (Herceptin)
IRB Number   CTSU SCUSF0806
Category   Bladder Cancer
Inclusion/Notes   HER2 (+)
LVEF-Left Heart Function at least at the lower limit's of institution's normal
Blood pressure within study parmeters


This study has multiple inclusion and exclusion criteria that individuals must meet to qualify for participation in the trila.
Status   Open
Start Date   08/25/2011
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan Koch, RN
Contact Email   jkoch@billingsclinic.org
Phone   (406) 435-7481
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.